Search clinical trials for: Oleclumab
Total 26 results
-
AstraZenecaCompleted
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
MedImmune LLCCompletedSolid TumorsUnited States, Korea, Republic of, Australia
-
University Health Network, TorontoRecruiting
-
AstraZenecaRecruitingNon-Small Cell Lung CancerChina, Australia, Korea, Republic of, Canada, Poland, Spain, Vietnam, Germany, Brazil, Italy, Japan, Taiwan, Thailand, United States, United Kingdom, Portugal, Turkey, France, Peru, Colombia, Russian Federation, Ukraine
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
University Health Network, TorontoAstraZenecaWithdrawnSquamous Cell Carcinoma of Head and Neck | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaCanada
-
MedImmune LLCCompletedNSCLC | Resectable | Early-stageUnited States, Canada, Switzerland, Italy, France, Portugal, Spain
-
Dana-Farber Cancer InstituteAstraZenecaCompletedMuscle Invasive Bladder CancerUnited States
-
University Health Network, TorontoAstraZenecaWithdrawnRenal Cell Carcinoma | Non Small Cell Lung CancerCanada
-
Jules Bordet InstituteAstraZeneca; Institut CurieActive, not recruiting
-
AstraZenecaCompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
MedImmune LLCActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Korea, Republic of, Taiwan
-
Assistance Publique Hopitaux De MarseilleRecruitingNon-small Cell Lung CancerFrance
-
Jules Bordet InstituteAstraZenecaActive, not recruitingTriple Negative Breast CancerFrance, Belgium
-
MedImmune LLCTerminatedMetastatic Microsatellite-stable Colorectal CancerUnited States, Spain, France, Australia, Canada
-
MedImmune LLCWithdrawnMicrosatellite-stable Colorectal Cancer
-
AstraZenecaRecruitingTriple Negative Breast NeoplasmsUnited States, Korea, Republic of, Canada, Taiwan, United Kingdom, Poland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Osteosarcoma | Refractory Osteosarcoma | Metastatic Osteosarcoma | Metastatic Angiosarcoma | Recurrent Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Recurrent Angiosarcoma | Refractory Dedifferentiated LiposarcomaUnited States
-
AstraZenecaActive, not recruitingMetastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, Belgium, Poland, Taiwan, Thailand, Korea, Republic of, Russian Federation, Austria
-
AstraZenecaParexelRecruitingNon-small Cell Lung CancerHungary, United States, Italy, Belgium, Spain, France, Korea, Republic of, Taiwan, Turkey, Ireland, Portugal, Canada
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerFrance, Spain, United States, Canada, Korea, Republic of, Austria, Israel, Germany
-
MedImmune LLCCompletedCarcinoma | Metastatic Pancreatic AdenocarcinomaUnited States, Spain, Australia, Norway
-
AstraZenecaCompletedAdvanced Solid Malignancies | Non-Small Cell Lung Cancer (NSCLC) | Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC) | Colorectal Carcinoma (CRC)United States
-
M.D. Anderson Cancer CenterRecruitingBorderline Resectable Pancreatic Adenocarcinoma | Stage IA Pancreatic Cancer AJCC v8 | Stage IB Pancreatic Cancer AJCC v8 | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | Resectable Pancreatic AdenocarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyRecruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Locally Advanced Lung Non-Small Cell Carcinoma | Locally Recurrent Lung Non-Small Cell CarcinomaUnited States